# Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome

> **NCT01587378** · NA · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 489 (actual)

## Conditions studied

- Pregnancy
- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01587378
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2017-10-31
- **Final completion:** 2017-10-31
- **Target enrollment:** 489 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01587378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01587378, "Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01587378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*